N-Desmethyl ofloxacin,
82419-52-1,
DESMETHYL-OFLOXACIN (5%),
Desmethyl Ofloxacin Hydrochloride,
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-,
9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid,
97791-27-0,
Ofloxacin related compound A,
N-Desmethyl ofloxacin, (+/-)-,
(RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,
Ofloxacin related compound A [USP],
Ofloxacin specified impurity E [EP],
Ofloxacin Impurity E,
Ofloxacin related compound A RS [USP],
ACMC-20el4o,
DESMETHYL-OFLOXACIN,
CHEMBL966,
SCHEMBL6246239,
CTK3E6482,
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-, (3S)-,
BDBM50229966,
STL452960,
AKOS027295018,
(3RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid,
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-,
N-Desmethyl ofloxacin, analytical standard,
FT-0666182,
FT-0701405,
C-33319,
Ofloxacin impurity E, European Pharmacopoeia (EP) Reference Standard,
Ofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard,
1,8-(1-Methylethane-1,2-diyloxy)-4-oxo-6-fluoro-7-piperazino-1,4-dihydroquinoline-3-carboxylic acid,
9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid,
Desmethylofloxacin,
Desmethyl levofloxacin,
UNII-5S4363I4ED,
5S4363I4ED,
Desmethyl Levofloxacin Hydrochloride,
CID11725233,
CID 10958963,
117707-40-1,
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID),